People who take proton pump inhibitors for gastric reflux may be at increased risk for contracting the virus that causes COVID-19, new research shows.
The study, of more than 86,000 people in the United States, found that those who reported using PPIs twice a day were nearly four times as likely to test positive for the SARS-CoV-2 virus as people who did not use the medications. The risk was elevated, though less dramatically, for people who used PPIs once daily. In contrast, use of